R&D Tax Incentive Substantiation Checklist

Imugene Ltd receives $6.5M R&D Tax Offset Refund

Melbourne-based Imugene Ltd announced in January 2022 the receipt of the company’s FY21 R&D Tax Offset refund of $6,541,921. The company has noted that the funds will support its commercial and clinical milestones, several of which have progressed in recent […]

ATO Release Finalised Tax Tuling TR 2021/5 (At Risk Rule)

Under SECT 355.405 ITAA97, an entity cannot claim R&D expenditure in situations where: (a) when an entity incurs R&D expenditure, consideration has been received, or was reasonably expected to be received: o as a direct or indirect result of the […]